Insmed Incorporated (NASDAQ:INSM) Overview

Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical company focused on developing therapies for rare diseases. The company is known for its innovative approach to addressing unmet medical needs. Insmed's competitors include other biotech firms that specialize in rare diseases, such as Vertex Pharmaceuticals and BioMarin Pharmaceutical.On February 19, 2026, Stifel Nicolaus set a price target of $205 for INSM, suggesting a potential upside of 28.22% from the stock's price of $159.88 at the time. This adj ...